KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) EBT Margin (2016 - 2025)

Historic EBT Margin for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to 20.06%.

  • West Pharmaceutical Services' EBT Margin fell 19600.0% to 20.06% in Q4 2025 from the same period last year, while for Dec 2025 it was 19.55%, marking a year-over-year decrease of 6900.0%. This contributed to the annual value of 19.55% for FY2025, which is 6900.0% down from last year.
  • West Pharmaceutical Services' EBT Margin amounted to 20.06% in Q4 2025, which was down 19600.0% from 21.36% recorded in Q3 2025.
  • West Pharmaceutical Services' 5-year EBT Margin high stood at 29.46% for Q2 2022, and its period low was 15.83% during Q1 2025.
  • Moreover, its 5-year median value for EBT Margin was 22.03% (2024), whereas its average is 22.61%.
  • As far as peak fluctuations go, West Pharmaceutical Services' EBT Margin skyrocketed by 98100bps in 2021, and later crashed by -67300bps in 2022.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' EBT Margin stood at 24.89% in 2021, then fell by -27bps to 18.16% in 2022, then rose by 27bps to 22.98% in 2023, then dropped by -4bps to 22.02% in 2024, then fell by -9bps to 20.06% in 2025.
  • Its EBT Margin was 20.06% in Q4 2025, compared to 21.36% in Q3 2025 and 20.48% in Q2 2025.